SEI Investments
VERV

SEI Investments’s Verve Therapeutics VERV Stock Holding History

SEI Investments’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-33,785
Closed -$379K – 2913
2025
Q2 		$379K Buy
33,785
+3,504
+12% +$20K ﹤0.01% 2305
2025
Q1 		$138K Buy
+30,281
New +$203K ﹤0.01% 2537

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SEI Investments's VERV Position: Q3 2025 in Review

SEI Investments sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 33,785 shares — an estimated $379K sold.

SEI Investments first reported a position in VERV in Q1 2025 and held it in 2 quarters. The position peaked at $379K in Q2 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • SEI Investments reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • SEI Investments sold 33,785 Verve Therapeutics shares in Q3 2025, an estimated $379K.
  • SEI Investments first reported a position in Verve Therapeutics in Q1 2025 and held it in 2 quarters.
  • SEI Investments's Verve Therapeutics position peaked at $379K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on SEI Investments's 13F filing for Q3 2025, filed 13 Nov 2025.